Literature DB >> 12197670

The renal expression of heat shock protein 47 and collagens in acute and chronic experimental diabetes in rats.

D Liu1, M S Razzaque, M Cheng, T Taguchi.   

Abstract

Glomerulosclerosis and tubulointerstitial fibrosis are the main structural changes found in the later stages of diabetic nephropathy, which is clinically characterized by proteinuria, and progressive renal insufficiency. Heat shock protein (HSP) 47, a collagen-binding stress protein, has a specific role in the intracellular processing of procollagen molecules during collagen synthesis. It is implicated in the pathogenesis of various fibrotic diseases. However, the expression and significance of HSP47 in acute and chronic phases of diabetic nephropathy is not yet known. In this study, we studied the expression of HSP47 in the kidneys obtained from streptozotocin-induced diabetic rats, in both short- and long-term diabetes. To determine the renal expression of HSP47, and collagens (type III and IV) in acute (days 1, 3 and 14) and chronic (weeks 4, 12 and 24) diabetes, we have performed a time-course study using streptozotocin-induced diabetic rats. The expression pattern of alpha-smooth muscle actin (to identify mesangial cell damage), vimentin (to identify tubular epithelial cell damage), and desmin (to identify glomerular epithelial cell damage) was also determined in kidneys of these diabetic rats. Antibodies specific for HSP47, type III and type IV collagens, alpha-smooth muscle actin, vimentin, and desmin were used to assess the relative expression of their proteins in paraffin-embedded kidney sections by immunohistochemistry. Compared to control rat kidneys, no significant changes in the expression of HSP47 was found in the kidneys of acute diabetic rats. However a significant increase in the expression of HSP47 was noted in the kidneys of chronic diabetic rats; increased expression of HSP47 correlated with an increased renal deposition of types III and IV collagens. Similarly, compared to kidneys of control and acute diabetic rats, an increased expression of alpha-smooth muscle actin (in mesangial cells), vimentin (in tubular epithelial cells), and desmin (in glomerular epithelial cells) was detected in the kidneys of chronic diabetic rats; by dual immunostaining, these phenotypically-altered renal cells in kidneys of chronic diabetic rats were found to be HSP47-producing cells. Importantly, HSP47 up-regulation coincided with the initiation and progression of renal fibrosis, as determined by the expression and deposition of collagens. Our results strongly support a pathological role for HSP47 in the later stages (sclerotic phase) of streptozotocin-induced diabetic nephropathy, which is associated with glomerulosclerosis and tubulointerstitial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12197670     DOI: 10.1023/a:1016398200087

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  14 in total

1.  Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1.

Authors:  Astri J Meen; Inger Øynebråten; Trine M Reine; Annette Duelli; Katja Svennevig; Gunnar Pejler; Trond Jenssen; Svein O Kolset
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

2.  HSP47 regulates ECM accumulation in renal proximal tubular cells induced by TGF-β1 through ERK1/2 and JNK MAPK pathways.

Authors:  Hong-bo Xiao; Rui-hong Liu; Guang-hui Ling; Li Xiao; Yuan-chen Xia; Fu-you Liu; Jun Li; Ying-hong Liu; Qin-kai Chen; Jin-lei Lv; Ming Zhan; Shi-kun Yang; Yashpal S Kanwar; Lin Sun
Journal:  Am J Physiol Renal Physiol       Date:  2012-06-20

3.  Molecular targets for diabetes mellitus-associated erectile dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; Moses T Tar; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

4.  Production and degradation of extracellular matrix in reversible glomerular lesions in rat model of habu snake venom-induced glomerulonephritis.

Authors:  Tayo Kawazu; Tomoya Nishino; Yoko Obata; Akira Furusu; Masanobu Miyazaki; Katsushige Abe; Takehiko Koji; Shigeru Kohno
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

Review 5.  Heat shock proteins in diabetes and wound healing.

Authors:  Mustafa Atalay; Niku Oksala; Jani Lappalainen; David E Laaksonen; Chandan K Sen; Sashwati Roy
Journal:  Curr Protein Pept Sci       Date:  2009-02       Impact factor: 3.272

6.  Heat shock protein 70 and albuminuria in patients with type 2 diabetes: a matched case control study.

Authors:  Afsaneh Morteza; Manouchehr Nakhjavani; Mehrdada Larry; Arash Aghajani Nargesi; Alireza Esteghamati
Journal:  Cell Stress Chaperones       Date:  2013-05-17       Impact factor: 3.667

7.  A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes.

Authors:  D Gong; J Lu; X Chen; S Reddy; D J Crossman; S Glyn-Jones; Y-S Choong; J Kennedy; B Barry; S Zhang; Y-K Chan; K Ruggiero; A R J Phillips; G J S Cooper
Journal:  Diabetologia       Date:  2008-07-18       Impact factor: 10.122

8.  Analysis of the mechanism of the tight-junctional permeability increase by capsaicin treatment on the intestinal Caco-2 cells.

Authors:  Junkyu Han; Hiroko Isoda; Takaaki Maekawa
Journal:  Cytotechnology       Date:  2002-11       Impact factor: 2.058

9.  Heat shock protein 47: a novel biomarker of phenotypically altered collagen-producing cells.

Authors:  Takashi Taguchi; Arifa Nazneen; Abdulmonem A Al-Shihri; Khadijah A Turkistani; Mohammed S Razzaque
Journal:  Acta Histochem Cytochem       Date:  2011-04-21       Impact factor: 1.938

10.  Serum Anti-Collagen IV IgM and IgG Antibodies as Indicators of Low Vascular Turnover of Collagen IV in Patients with Long-Term Complications of Type 2 Diabetes.

Authors:  Krasimir Kostov; Alexander Blazhev
Journal:  Diagnostics (Basel)       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.